Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliette Janson

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Diabetes|August 28, 2003
Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloidAlexandra E Butler, Juliette Janson, Walter C Soeller, et al.
Molecular Genetics and Metabolism Reports|January 8, 2020
Impact of chemical modification of sulfamidase on distribution to brain interstitial fluid and to CSF after an intravenous administration in awake, freely-moving ratsJuliette Janson, Gudrun Andersson, Lars Bergquist, et al.
Diabetes|January 30, 2004
Increased risk of type 2 diabetes in Alzheimer diseaseJuliette Janson, Thomas Laedtke, Joseph E Parisi, et al.
Diabetes|December 28, 2002
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetesAlexandra E Butler, Juliette Janson, Susan Bonner-Weir, et al.
Bioanalysis|February 19, 2013
Capillary microsampling and analysis of 4-µl blood, plasma and serum samples to determine human α-synuclein elimination rate in miceOve Jonsson, Ann-Charlott Steffen, Valentina Screpanti Sundquist, et al.
Bioanalysis|September 7, 2019
Robust LC-MS/MS methods for analysis of heparan sulfate levels in CSF and brain for application in studies of MPS IIIAÅsa Makower, Erik Arnelöf, Tommy Andersson, et al.
Pharmaceutical Research|October 5, 2013
Population PKPD modeling of BACE1 inhibitor-induced reduction in Aβ levels in vivo and correlation to in vitro potency in primary cortical neurons from mouse and guinea pigJuliette Janson, Susanna Eketjäll, Karin Tunblad, et al.
Diabetes|March 1, 2006
Tomosyn is expressed in beta-cells and negatively regulates insulin exocytosisWei Zhang, Lena Lilja, Slavena A Mandic, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2016
AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate KineticsSusanna Eketjäll, Juliette Janson, Karin Kaspersson, et al.
Molecular Genetics and Metabolism Reports|September 19, 2019
Intravenous delivery of a chemically modified sulfamidase efficiently reduces heparan sulfate storage and brain pathology in mucopolysaccharidosis IIIA miceSusanne Gustavsson, Elisabet Ohlin Sjöström, Agneta Tjernberg, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Diabetes|August 28, 2003
Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloidAlexandra E Butler, Juliette Janson, Walter C Soeller, et al.
Molecular Genetics and Metabolism Reports|January 8, 2020
Impact of chemical modification of sulfamidase on distribution to brain interstitial fluid and to CSF after an intravenous administration in awake, freely-moving ratsJuliette Janson, Gudrun Andersson, Lars Bergquist, et al.
Diabetes|January 30, 2004
Increased risk of type 2 diabetes in Alzheimer diseaseJuliette Janson, Thomas Laedtke, Joseph E Parisi, et al.
Diabetes|December 28, 2002
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetesAlexandra E Butler, Juliette Janson, Susan Bonner-Weir, et al.
Bioanalysis|February 19, 2013
Capillary microsampling and analysis of 4-µl blood, plasma and serum samples to determine human α-synuclein elimination rate in miceOve Jonsson, Ann-Charlott Steffen, Valentina Screpanti Sundquist, et al.
Bioanalysis|September 7, 2019
Robust LC-MS/MS methods for analysis of heparan sulfate levels in CSF and brain for application in studies of MPS IIIAÅsa Makower, Erik Arnelöf, Tommy Andersson, et al.
Pharmaceutical Research|October 5, 2013
Population PKPD modeling of BACE1 inhibitor-induced reduction in Aβ levels in vivo and correlation to in vitro potency in primary cortical neurons from mouse and guinea pigJuliette Janson, Susanna Eketjäll, Karin Tunblad, et al.
Diabetes|March 1, 2006
Tomosyn is expressed in beta-cells and negatively regulates insulin exocytosisWei Zhang, Lena Lilja, Slavena A Mandic, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2016
AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate KineticsSusanna Eketjäll, Juliette Janson, Karin Kaspersson, et al.
Molecular Genetics and Metabolism Reports|September 19, 2019
Intravenous delivery of a chemically modified sulfamidase efficiently reduces heparan sulfate storage and brain pathology in mucopolysaccharidosis IIIA miceSusanne Gustavsson, Elisabet Ohlin Sjöström, Agneta Tjernberg, et al.
Pageof 2